New Amsterdam Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.97M Buy
42,439
+3,794
+10% +$192K 0.72% 53
2018
Q4
$1.9M Sell
38,645
-3,421
-8% -$195K 0.62% 62
2018
Q3
$2.61M Sell
42,066
-1,758
-4% -$107K 0.67% 62
2018
Q2
$2.36M Sell
43,824
-3,780
-8% -$189K 0.56% 68
2018
Q1
$2.17M Buy
+47,604
New +$2.04M 0.47% 72
2017
Q3
Sell
-35,412
Closed -$1.36M 124
2017
Q2
$1.36M Buy
+35,412
New +$1.3M 0.29% 83

Other funds holding EHC

New Amsterdam Partners's EHC Position: Q1 2019 in Review

New Amsterdam Partners increased its Encompass Health (EHC) stake by 9.8% in Q1 2019, buying an estimated $192K and bringing the position to 42,439 shares worth $1.97M. The position accounts for 0.72% of the portfolio, ranked #53.

New Amsterdam Partners first reported a position in EHC in Q2 2017 and has held it in 6 quarters since. The position peaked at $2.61M in Q3 2018. 427 funds tracked by Wall St. Rank hold EHC as of Q1 2019.

  • New Amsterdam Partners held 42,439 shares of Encompass Health worth $1.97M as of Q1 2019.
  • New Amsterdam Partners bought 3,794 Encompass Health shares in Q1 2019, an estimated $192K.
  • Encompass Health made up 0.72% of New Amsterdam Partners's portfolio in Q1 2019, its #53 holding.
  • New Amsterdam Partners first reported a position in Encompass Health in Q2 2017 and has held it in 6 quarters since.
  • New Amsterdam Partners's Encompass Health position peaked at $2.61M in Q3 2018.
  • 427 funds tracked by Wall St. Rank held Encompass Health as of Q1 2019.

Based on New Amsterdam Partners's 13F filing for Q1 2019, filed 2 May 2019.